[go: up one dir, main page]

EE9700061A - Farmatseutiline aerosoolpreparaat ja selle valmistamismeetod - Google Patents

Farmatseutiline aerosoolpreparaat ja selle valmistamismeetod

Info

Publication number
EE9700061A
EE9700061A EE9700061A EE9700061A EE9700061A EE 9700061 A EE9700061 A EE 9700061A EE 9700061 A EE9700061 A EE 9700061A EE 9700061 A EE9700061 A EE 9700061A EE 9700061 A EE9700061 A EE 9700061A
Authority
EE
Estonia
Prior art keywords
preparation
aerosol formulation
pharmaceutical aerosol
pharmaceutical
formulation
Prior art date
Application number
EE9700061A
Other languages
English (en)
Other versions
EE03380B1 (et
Inventor
Arthur Johnson Keith
Li-Bovet Li
Original Assignee
Glaxo Wellcome Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Wellcome Inc. filed Critical Glaxo Wellcome Inc.
Publication of EE9700061A publication Critical patent/EE9700061A/et
Publication of EE03380B1 publication Critical patent/EE03380B1/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/10—Phosphatides, e.g. lecithin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
EE9700061A 1994-09-28 1995-09-27 Farmatseutiline aerosoolpreparaat ja selle valmistamismeetod EE03380B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9419536A GB9419536D0 (en) 1994-09-28 1994-09-28 Medicaments
PCT/IB1995/000866 WO1996009816A1 (en) 1994-09-28 1995-09-27 Medicaments

Publications (2)

Publication Number Publication Date
EE9700061A true EE9700061A (et) 1997-08-15
EE03380B1 EE03380B1 (et) 2001-04-16

Family

ID=10762008

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9700061A EE03380B1 (et) 1994-09-28 1995-09-27 Farmatseutiline aerosoolpreparaat ja selle valmistamismeetod

Country Status (32)

Country Link
US (1) US5849265A (et)
EP (1) EP0783302B1 (et)
JP (1) JPH10506887A (et)
KR (1) KR100375469B1 (et)
CN (1) CN1084614C (et)
AP (1) AP742A (et)
AT (1) ATE187063T1 (et)
AU (1) AU707922B2 (et)
BG (1) BG62839B1 (et)
BR (1) BR9509108A (et)
CZ (1) CZ286356B6 (et)
DE (1) DE69513671T2 (et)
DK (1) DK0783302T3 (et)
EE (1) EE03380B1 (et)
ES (1) ES2140706T3 (et)
FI (1) FI971279A (et)
GB (1) GB9419536D0 (et)
GE (1) GEP20002140B (et)
GR (1) GR3032245T3 (et)
HU (1) HU221856B1 (et)
IS (1) IS1991B (et)
MD (1) MD1900C2 (et)
MX (1) MX9702149A (et)
NO (1) NO313658B1 (et)
NZ (1) NZ292995A (et)
OA (1) OA10603A (et)
PL (1) PL181453B1 (et)
RO (1) RO118564B1 (et)
RU (1) RU2157188C2 (et)
SK (1) SK281519B6 (et)
UA (1) UA47412C2 (et)
WO (1) WO1996009816A1 (et)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9410222D0 (en) * 1994-05-21 1994-07-06 Glaxo Wellcome Australia Ltd Medicaments
US6039932A (en) * 1996-09-27 2000-03-21 3M Innovative Properties Company Medicinal inhalation aerosol formulations containing budesonide
US6598603B1 (en) * 1997-12-31 2003-07-29 Astra Aktiebolag Method for treating respiratory diseases
US6984404B1 (en) 1998-11-18 2006-01-10 University Of Florida Research Foundation, Inc. Methods for preparing coated drug particles and pharmaceutical formulations thereof
WO2000061108A1 (en) * 1999-04-14 2000-10-19 Glaxo Group Limited Pharmaceutical aerosol formulation
US6406745B1 (en) * 1999-06-07 2002-06-18 Nanosphere, Inc. Methods for coating particles and particles produced thereby
GB0009606D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Therapeutic combinations
US6451287B1 (en) 2000-05-26 2002-09-17 Smithkline Beecham Corporation Fluorinated copolymer surfactants and use thereof in aerosol compositions
GB0016876D0 (en) * 2000-07-11 2000-08-30 Astrazeneca Ab Novel formulation
US6750210B2 (en) * 2000-08-05 2004-06-15 Smithkline Beecham Corporation Formulation containing novel anti-inflammatory androstane derivative
US6777400B2 (en) * 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6777399B2 (en) * 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6858593B2 (en) * 2000-08-05 2005-02-22 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6759398B2 (en) 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
GB0019172D0 (en) * 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
US6858596B2 (en) * 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
US6787532B2 (en) * 2000-08-05 2004-09-07 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivatives
SK287576B6 (sk) * 2000-08-05 2011-03-04 Glaxo Group Limited S-fluórmetylester kyseliny 6alfa, 9alfa-difluór-17alfa-[(2- furanylkarboxyl)oxy]-11beta-hydroxy-16alfa-metyl-3-oxo-androsta- 1,4-dién-17beta-karbotiovej, spôsob jeho prípravy, farmaceutický prostriedok s jeho obsahom, jeho použitie a medziprodukty
AU2001290075A1 (en) 2000-09-22 2002-04-02 Glaxo Group Limited Novel alkanoic acid derivatives
GB0106046D0 (en) 2001-03-12 2001-05-02 Glaxo Group Ltd Canister
UA77656C2 (en) * 2001-04-07 2007-01-15 Glaxo Group Ltd S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
IL158222A0 (en) * 2001-04-30 2004-05-12 Glaxo Group Ltd Anti-inflammatory 17. beta-carbothioate ester derivatives of androstane with a cyclic ester group in position 17. alpha
ATE399174T1 (de) * 2001-06-12 2008-07-15 Glaxo Group Ltd Neue anti inflammatorische 17.alpha.- heterozyklische ester von 17.beta.-carbothioat androstan derivativen
GB0118364D0 (en) * 2001-07-27 2001-09-19 Glaxo Group Ltd Compounds
PL368805A1 (en) * 2001-08-03 2005-04-04 Glaxo Group Limited Surfactant compounds and uses thereof
GB0125127D0 (en) 2001-10-19 2001-12-12 Glaxo Group Ltd Compounds
US20030140920A1 (en) * 2001-10-26 2003-07-31 Dey L.P. Albuterol inhalation soultion, system, kit and method for relieving symptoms of pediatric asthma
US6702997B2 (en) 2001-10-26 2004-03-09 Dey, L.P. Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma
US20030191151A1 (en) * 2001-10-26 2003-10-09 Imtiaz Chaudry Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
US20030203930A1 (en) * 2001-10-26 2003-10-30 Imtiaz Chaudry Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
JP2003221335A (ja) 2001-10-26 2003-08-05 Dey Lp 慢性閉塞性肺疾患の症状を緩和するためのアルブテロールおよびイプラトロピウム吸入溶液、システム、キットおよび方法
US20050175545A1 (en) * 2002-02-04 2005-08-11 Keith Biggadike Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist
GB0202635D0 (en) * 2002-02-05 2002-03-20 Glaxo Wellcome Mfg Pte Ltd Formulation containing novel anti-inflammatory androstane derivative
CN1633407A (zh) 2002-02-13 2005-06-29 葛兰素集团有限公司 用作表面活性剂的羧酸化合物
GB0205327D0 (en) * 2002-03-06 2002-04-17 Glaxo Group Ltd compounds
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
TWI359675B (en) * 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
EP1654312B1 (en) 2003-08-11 2014-01-15 Glaxo Group Limited Pharmaceutical metered dose inhaler and methods relating thereto
CA2536876A1 (en) 2003-08-29 2005-03-17 Glaxo Group Limited Pharmaceutical metered dose inhaler and methods relating thereto
US7030255B2 (en) * 2004-03-09 2006-04-18 Lyondell Chemical Technology, L.P. Oxidation process with in-situ H202 generation and polymer-encapsulated catalysts therefor
EP1949891A1 (en) 2004-10-12 2008-07-30 Generics (UK) Limited Process for the preparation of suspension aerosol formulations, wherein the particles are formed by precipitation inside an aerosol canister
WO2006040598A2 (en) * 2004-10-12 2006-04-20 Generics (Uk) Limited Process for the preparation of suspension aerosol formulations, wherein the particles are formed by precipitation inside an aerosol canister
GB0507165D0 (en) * 2005-04-08 2005-05-18 Glaxo Group Ltd Novel crystalline pharmaceutical product
GB0615108D0 (en) * 2006-07-28 2006-09-06 Glaxo Group Ltd Novel formulations
DK2120875T3 (en) * 2007-02-11 2018-10-22 Map Pharmaceuticals Inc METHOD OF THERAPEUTIC ADMINISTRATION OF DHE TO POSSIBLE QUICK PREVENTION OF MIGRANE AT THE MINIMUM OF THE SIDE EFFECT PROFILE
GB0712454D0 (en) * 2007-06-27 2007-08-08 Generics Uk Ltd Pharmaceutical compositions

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4352789A (en) * 1980-03-17 1982-10-05 Minnesota Mining And Manufacturing Company Aerosol compositions containing finely divided solid materials
GB8501015D0 (en) * 1985-01-16 1985-02-20 Riker Laboratories Inc Drug
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
ES2060184T3 (es) * 1989-06-22 1994-11-16 Atta Moleculas anfifilicas conteniendo fluor y fosforo con propiedades tensoactivas.
GB8921222D0 (en) * 1989-09-20 1989-11-08 Riker Laboratories Inc Medicinal aerosol formulations
IL97065A (en) * 1990-02-02 1994-01-25 Fisons Plc Repellent preparations for aerosol
DE4003272A1 (de) * 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgasmischungen und ihre verwendung in arzneimittelzubereitungen
DE69109284T2 (de) * 1990-03-23 1995-08-24 Minnesota Mining And Mfg. Co., Saint Paul, Minn. Verwendung von fluorierten löslichen tensiden zur herstellung von aerosolarzneimitteln mit dosierter abgabe.
WO1992000062A1 (en) * 1990-06-27 1992-01-09 Minnesota Mining And Manufacturing Company The use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations
US5126123A (en) * 1990-06-28 1992-06-30 Glaxo, Inc. Aerosol drug formulations

Also Published As

Publication number Publication date
WO1996009816A1 (en) 1996-04-04
KR100375469B1 (ko) 2003-10-17
NO971422D0 (no) 1997-03-25
HU221856B1 (hu) 2003-02-28
CN1084614C (zh) 2002-05-15
NZ292995A (en) 1998-10-28
IS4438A (is) 1997-03-10
PL319342A1 (en) 1997-08-04
MD1900B2 (en) 2002-04-30
CZ286356B6 (cs) 2000-03-15
NO313658B1 (no) 2002-11-11
EP0783302B1 (en) 1999-12-01
AU707922B2 (en) 1999-07-22
ATE187063T1 (de) 1999-12-15
DE69513671D1 (de) 2000-01-05
EP0783302A1 (en) 1997-07-16
CZ93697A3 (en) 1997-08-13
OA10603A (en) 2002-08-30
GB9419536D0 (en) 1994-11-16
CN1168630A (zh) 1997-12-24
NO971422L (no) 1997-05-23
MX9702149A (es) 1998-04-30
RU2157188C2 (ru) 2000-10-10
RO118564B1 (ro) 2003-07-30
BG101347A (en) 1997-12-30
UA47412C2 (uk) 2002-07-15
BG62839B1 (bg) 2000-09-29
PL181453B1 (pl) 2001-07-31
DE69513671T2 (de) 2000-04-06
BR9509108A (pt) 1998-07-14
SK39397A3 (en) 1997-10-08
GEP20002140B (en) 2000-06-25
IS1991B (is) 2005-02-15
EE03380B1 (et) 2001-04-16
SK281519B6 (sk) 2001-04-09
FI971279A0 (fi) 1997-03-26
US5849265A (en) 1998-12-15
MD1900C2 (ro) 2002-12-31
ES2140706T3 (es) 2000-03-01
HUT77377A (hu) 1998-04-28
FI971279A (fi) 1997-03-26
AP742A (en) 1999-04-26
MD970134A (en) 1999-02-28
DK0783302T3 (da) 2000-05-29
AP9700951A0 (en) 1997-04-30
GR3032245T3 (en) 2000-04-27
AU3532195A (en) 1996-04-19
JPH10506887A (ja) 1998-07-07
KR970705981A (ko) 1997-11-03

Similar Documents

Publication Publication Date Title
EE9700061A (et) Farmatseutiline aerosoolpreparaat ja selle valmistamismeetod
FI972657A0 (fi) Proteiinien ja peptidien aerosoliformuloinnit
EE03742B1 (et) Tramadooli mitmikühikulised preparaadid ja nende valmistamismeetod
EE9700145A (et) Tsükloalkaanpüridiinid, nende valmistamismeetod, kasutamine ravimite tootmiseks ja nimetatud ühendeid sisaldavad ravimid
BR9500784A (pt) Composto e formulação farmacêutica
BR9504060A (pt) Composto e formulação farmacêutica
EE03976B1 (et) Erütromütsiinid ja nende valmistamise meetod
BR9504509A (pt) Composto processo para sua preparaçao e formulaçao farmaceûtica
EE9800180A (et) Gonadotropiini riliisinghormooni antagonist, selle kasutamine, farmatseutiline kompositsioon ja selle valmistamismeetod
EE9800181A (et) Gonadotropiini riliisinghormooni antagonist, selle kasutamine, farmatseutiline kompositsioon ja selle valmistamismeetod
EE04021B1 (et) 7a-( -aminoalküül)östratrieenid, nende valmistamise meetod, 7a-( -aminoalküül)östratrieene sisaldavad farmatseutilised preparaadid ja nende kasutamine ravimite valmistamiseks
EE9700328A (et) Tahke oraalne preparaat, mis sisaldab toimeainena olansapiini, selle valmistamismeetod ja kasutamine
FI953479A0 (fi) 1-aryylipyrimidiinijohdannaiset ja niiden farmaseuttinen käyttö
EE9800119A (et) Mikrokapseldatud putukamürgi preparaadid ja protsess nende valmistamiseks
AUPO727097A0 (en) Method of treatment of hepatoma and pharmaceutical compositions for use therein
EE9600172A (et) Puriin-6-ooni derivaadid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja ravimid
EE9800234A (et) Ravimeetod ja farmatseutiline kompositsioon
BR9602915A (pt) Medicamentos uso e formulação farmacêutica
EE9800161A (et) Vähivaktsiin ja selle valmistamismeetod
EE200000226A (et) 3,6-poolketaalid 9a-asaliidide klassist, nende valmistamismeetod ja farmatseutiline kompositsioon
IL113431A0 (en) Naphthalene derivatives method of preparation and use and pharmaceutical compositions containing them
FI942932A0 (fi) Farmaseuttinen koostumus ja menetelmä sen valmistamiseksi
EE03669B1 (et) Vedelad alendronaatpreparaadid ja nende valmistamismeetod
EE9800075A (et) Kombineeritud ravimpreparaat, selle kasutamine ja meetod selle valmistamiseks
ITMI951417A0 (it) Composizioni farmaceutiche e procedimento per la loro preparazione

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

MM4A Lapsed by not paying the annual fees

Effective date: 20080927